Xenon Pharmaceuticals Statistics

Total Valuation

XENE has a market cap or net worth of $5.77 billion. The enterprise value is $4.44 billion.

Market Cap	5.77B
Enterprise Value	4.44B

Important Dates

The next estimated earnings date is Monday, August 10, 2026, after market close.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

XENE has 96.67 million shares outstanding. The number of shares has increased by 4.16% in one year.

Current Share Class	96.67M
Shares Outstanding	96.67M
Shares Change (YoY)	+4.16%
Shares Change (QoQ)	+9.01%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	97.41%
Float	90.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	3,346.00
PB Ratio	4.31
P/TBV Ratio	4.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 27.79, with a Debt / Equity ratio of 0.01.

Current Ratio	27.79
Quick Ratio	27.53
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -37.53% and return on invested capital (ROIC) is -25.07%.

Return on Equity (ROE)	-37.53%
Return on Assets (ROA)	-24.22%
Return on Invested Capital (ROIC)	-25.07%
Return on Capital Employed (ROCE)	-30.64%
Weighted Average Cost of Capital (WACC)	7.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	370
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.98M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +88.10% in the last 52 weeks. The beta is 0.63, so XENE's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+88.10%
50-Day Moving Average	54.85
200-Day Moving Average	46.90
Relative Strength Index (RSI)	71.44
Average Volume (20 Days)	1,753,432

Short Selling Information

The latest short interest is 4.04 million, so 4.18% of the outstanding shares have been sold short.

Short Interest	4.04M
Short Previous Month	3.83M
Short % of Shares Out	4.18%
Short % of Float	4.46%
Short Ratio (days to cover)	3.39

Income Statement

Revenue	n/a
Gross Profit	-328.25M
Operating Income	-412.66M
Pretax Income	-385.15M
Net Income	-383.17M
EBITDA	-410.19M
EBIT	-412.66M
Earnings Per Share (EPS)	-$4.71

Full Income Statement

Balance Sheet

The company has $1.09 billion in cash and $7.49 million in debt, giving a net cash position of $1.33 billion or $13.78 per share.

Cash & Cash Equivalents	1.09B
Total Debt	7.49M
Net Cash	1.33B
Net Cash Per Share	$13.78
Equity (Book Value)	1.34B
Book Value Per Share	13.85
Working Capital	1.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$306.36 million and capital expenditures -$889,000, giving a free cash flow of -$307.25 million.

Operating Cash Flow	-306.36M
Capital Expenditures	-889,000
Depreciation & Amortization	2.47M
Net Borrowing	n/a
Free Cash Flow	-307.25M
FCF Per Share	-$3.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XENE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.16%
Shareholder Yield	n/a
Earnings Yield	-6.64%
FCF Yield	-5.32%

Analyst Forecast

The average price target for XENE is $80.56, which is 34.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$80.56
Price Target Difference	34.85%
Analyst Consensus	Strong Buy
Analyst Count	20
Revenue Growth Forecast (3Y)	226.24%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XENE has an Altman Z-Score of 36.19 and a Piotroski F-Score of 2.

Altman Z-Score	36.19
Piotroski F-Score	2